Schonfeld Strategic Advisors LLC Tarsus Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15.4 Billion
- Q4 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 9,800 shares of TARS stock, worth $489,706. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,800
Previous 187,513
94.77%
Holding current value
$489,706
Previous $6.17 Million
91.21%
% of portfolio
0.0%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding TARS
# of Institutions
200Shares Held
40.4MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$163 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$162 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$127 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$125 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$113 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.33B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...